I used the recent surge to sell most of my deep ITM calls and lost most of my shares by writing covered calls at $13. Glad the stock finished at 13.01 on Op-Ex, so that the covered calls got exercised.
I think a covered call strategy for half the shares (if I can get back in below $12) is a good strategy, as the premiums are decent.
On May 6, 2014, Momenta Pharmaceuticals, Inc. (the “Company”) entered into an At-The-Market Equity Offering Sales Agreement (the “Sales Agreement”) with Stifel, Nicolaus & Company, Incorporated (“Stifel”) pursuant to which the Company may sell from time to time, at its option, up to an aggregate of $75.0 million of its shares of common stock through Stifel